Tony Rosenberg

Tony Rosenberg is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chairman of the Board at Cullinan Oncology and OCULIS SA, Rosenberg is also a Board Member at argenx. Additionally, as Chief Executive Officer of TR ADVISORY SERVICES since April 2015, Rosenberg has contributed to various organizations, including a tenure as Managing Director at MPM Capital until April 2020. Previous roles include Board Member at TriNetX and Head of M&A/Licensing at Novartis International from 2005 to 2015. Rosenberg holds a Master of Science degree from the University of London and a Bachelor of Science degree from the University of Leicester.